Answers are grounded in this paper and cite their sources.
Computational framework identifies omic biomarkers in chronic inflammatory diseases, enhancing prediction accuracy.
Background Chronic inflammatory diseases, such as ulcerative colitis (UC), Crohn’s disease (CD), Alzheimer’s disease (AD) and Parkinson’s disease (PD) are clinically related to periodontitis. However, the computation of omic biomarkers regarding these diseases has not leveraged this association. Methods We developed PMGCN, a computational framework that employs optimal percolations on multi-disease gene co-expression networks derived from bulk transcriptomic gene expression profiles to identify a parsimonious set of key nodes as candidate omic biomarkers. Results Evaluation of PMGCN on independent clinical studies of four chronic inflammatory diseases demonstrates improved predictive performance evaluated via cross validation with bootstrapping compared to commonly used univariate differentially expressed genes. Specifically for UC, three key gene biomarkers (CXCL5, FOSB, PTGR1) are identified by PMGCN, and public single-cell RNA-seq datasets confirm that the mainly altered inflammation signaling pathways in three cell clusters are connected to UC and periodontitis progression. Conclusions PMGCN proposes a computational biomarker identification approach leveraging multi-disease association, the discovered gene biomarkers demonstrate improved prediction of chronic inflammatory diseases and provide novel insights into disease progression.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: